Cargando…

SAT307 Intraoperative Radiofrequency Ablation Of An Unresectable Abdominal Paraganglioma Promoted Objective Tumor Response And Complete Biochemical Remission

Disclosure: I.P. de Magalhães: None. B.S. Boger: None. N.L. Gomes: None. G.L. Martins: None. L.A. Bomfim Jr: None. G.F. Fagundes: None. A.F. Afonso: None. J. Petenuci: None. F.M. Coelho: None. V. Srougi: None. F.Y. Tanno: None. J.L. Chambo: None. A. Latronico: None. M.B. Fragoso: None. A.O. Hoff: No...

Descripción completa

Detalles Bibliográficos
Autores principales: de Magalhães, Isabelle P A, Boger, Bibiana S, Gomes, Nathalia L R A, Martins, Guilherme L P, Bomfim, Leomarques A, Fagundes, Gustavo F C, Afonso, Ana Caroline F, Petenuci, Janaina, Coelho, Fernando M A, Srougi, Victor, Tanno, Fabio Y, Chambo, Jose L, Latronico, Ana Claudia, Fragoso, Maria Candida B V, Hoff, Ana O, Mendonca, Berenice B, Menezes, Marcos R, Almeida, Madson Q
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557017/
http://dx.doi.org/10.1210/jendso/bvad114.311
_version_ 1785116997204312064
author de Magalhães, Isabelle P A
Boger, Bibiana S
Gomes, Nathalia L R A
Martins, Guilherme L P
Bomfim, Leomarques A
Fagundes, Gustavo F C
Afonso, Ana Caroline F
Petenuci, Janaina
Coelho, Fernando M A
Srougi, Victor
Tanno, Fabio Y
Chambo, Jose L
Latronico, Ana Claudia
Fragoso, Maria Candida B V
Hoff, Ana O
Mendonca, Berenice B
Menezes, Marcos R
Almeida, Madson Q
author_facet de Magalhães, Isabelle P A
Boger, Bibiana S
Gomes, Nathalia L R A
Martins, Guilherme L P
Bomfim, Leomarques A
Fagundes, Gustavo F C
Afonso, Ana Caroline F
Petenuci, Janaina
Coelho, Fernando M A
Srougi, Victor
Tanno, Fabio Y
Chambo, Jose L
Latronico, Ana Claudia
Fragoso, Maria Candida B V
Hoff, Ana O
Mendonca, Berenice B
Menezes, Marcos R
Almeida, Madson Q
author_sort de Magalhães, Isabelle P A
collection PubMed
description Disclosure: I.P. de Magalhães: None. B.S. Boger: None. N.L. Gomes: None. G.L. Martins: None. L.A. Bomfim Jr: None. G.F. Fagundes: None. A.F. Afonso: None. J. Petenuci: None. F.M. Coelho: None. V. Srougi: None. F.Y. Tanno: None. J.L. Chambo: None. A. Latronico: None. M.B. Fragoso: None. A.O. Hoff: None. B.B. Mendonca: None. M.R. Menezes: None. M.Q. Almeida: None. Background: Metastatic pheochromocytoma and paraganglioma (PPGL) are incurable neuroendocrine tumors. Few reports demonstrated the efficacy of radiofrequency ablation (RFA) in achieving tumor control of metastatic lesions (usually <3 cm). However, intraoperative RFA of large and unresectable primary PPGLs was not previously demonstrated. Case Report: A 31-year-old male patient was diagnosed with symptoms of catecholamine excess, high levels of plasma metanephrines and a 9 cm retroperitoneal tumor. The patient underwent an open laparotomy, which revealed unresectable disease. Anatomopathological and immunohistochemical analysis was compatible with the diagnosis of paraganglioma. The patient was treated with 13 cycles of cytotoxic chemotherapy (cyclophosphamide, vincristine and dacarbazine) without objective tumor response by RECIST. Then, he was referred to our Institution for evaluation of additional therapies. Blood pressured was well controlled with doxazosin 16 mg/d, propranolol 40 mg/d and losartan 100 mg/d. A magnetic resonance imaging (MRI) revealed an extensive retroperitoneal mass with 9.0 x 8.6 x 6.0 cm (208 ml) that involved the inferior portion of the vein inferior vena cava, inferior mesenteric artery and infrarenal aorta. Biochemical evaluation demonstrated very high levels of plasma normetanephrine (20.2 nmol/L; normal range <0.9 nmol/L) and normal metanephrine level (0.2 nmol/L; <0.5 nmol/L). The genetic investigation showed the germline pathogenic variant c.1591delC (p.Ser198Alafs*22) in SDHB gene. I(131)-metaiodobenzylguanidine scintigraphy was negative and Ga(68)-dotatate PET-CT scan displayed a high uptake in the abdominal mass without metastatic disease. Unfortunately, lutetium(177) treatment is not available in our Institution. Due to the lack of alternative therapies, we proposed a debulking open laparotomy with intraoperative RFA in the remaining tumoral lesion. Nevertheless, the tumor did not present a clear cleavage plane with the large vessels and had a large caliber intratumoral vasculature. Intraoperative RFA was performed by a very experienced team (interventional radiologist and anesthesiologist to control blood pressure during the procedure). After 2 months, the dose of doxazosin decreased from 16 mg to 8 mg (50% reduction), plasma normetanephrines dropped to 4.6 nmol/L (79%), and the largest tumor diameter at MRI reduced to 6.8 cm (88.8 ml, 57% reduction). After 7 months of the RFA procedure, the tumor continues shrinking (4.8 cm, 45 ml, 78% reduction) and plasma normetanephrine completely normalized. Conclusion: This is the first report of intraoperative RFA of a large primary unresectable paraganglioma. The patient presented a striking clinical success, complete biochemical remission and an objective tumor response. Support: Sao Paulo Research Foundation (FAPESP) grant 2019/15873-6 (to M.Q. Almeida). Presentation: Saturday, June 17, 2023
format Online
Article
Text
id pubmed-10557017
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-105570172023-10-07 SAT307 Intraoperative Radiofrequency Ablation Of An Unresectable Abdominal Paraganglioma Promoted Objective Tumor Response And Complete Biochemical Remission de Magalhães, Isabelle P A Boger, Bibiana S Gomes, Nathalia L R A Martins, Guilherme L P Bomfim, Leomarques A Fagundes, Gustavo F C Afonso, Ana Caroline F Petenuci, Janaina Coelho, Fernando M A Srougi, Victor Tanno, Fabio Y Chambo, Jose L Latronico, Ana Claudia Fragoso, Maria Candida B V Hoff, Ana O Mendonca, Berenice B Menezes, Marcos R Almeida, Madson Q J Endocr Soc Adrenal (Excluding Mineralocorticoids) Disclosure: I.P. de Magalhães: None. B.S. Boger: None. N.L. Gomes: None. G.L. Martins: None. L.A. Bomfim Jr: None. G.F. Fagundes: None. A.F. Afonso: None. J. Petenuci: None. F.M. Coelho: None. V. Srougi: None. F.Y. Tanno: None. J.L. Chambo: None. A. Latronico: None. M.B. Fragoso: None. A.O. Hoff: None. B.B. Mendonca: None. M.R. Menezes: None. M.Q. Almeida: None. Background: Metastatic pheochromocytoma and paraganglioma (PPGL) are incurable neuroendocrine tumors. Few reports demonstrated the efficacy of radiofrequency ablation (RFA) in achieving tumor control of metastatic lesions (usually <3 cm). However, intraoperative RFA of large and unresectable primary PPGLs was not previously demonstrated. Case Report: A 31-year-old male patient was diagnosed with symptoms of catecholamine excess, high levels of plasma metanephrines and a 9 cm retroperitoneal tumor. The patient underwent an open laparotomy, which revealed unresectable disease. Anatomopathological and immunohistochemical analysis was compatible with the diagnosis of paraganglioma. The patient was treated with 13 cycles of cytotoxic chemotherapy (cyclophosphamide, vincristine and dacarbazine) without objective tumor response by RECIST. Then, he was referred to our Institution for evaluation of additional therapies. Blood pressured was well controlled with doxazosin 16 mg/d, propranolol 40 mg/d and losartan 100 mg/d. A magnetic resonance imaging (MRI) revealed an extensive retroperitoneal mass with 9.0 x 8.6 x 6.0 cm (208 ml) that involved the inferior portion of the vein inferior vena cava, inferior mesenteric artery and infrarenal aorta. Biochemical evaluation demonstrated very high levels of plasma normetanephrine (20.2 nmol/L; normal range <0.9 nmol/L) and normal metanephrine level (0.2 nmol/L; <0.5 nmol/L). The genetic investigation showed the germline pathogenic variant c.1591delC (p.Ser198Alafs*22) in SDHB gene. I(131)-metaiodobenzylguanidine scintigraphy was negative and Ga(68)-dotatate PET-CT scan displayed a high uptake in the abdominal mass without metastatic disease. Unfortunately, lutetium(177) treatment is not available in our Institution. Due to the lack of alternative therapies, we proposed a debulking open laparotomy with intraoperative RFA in the remaining tumoral lesion. Nevertheless, the tumor did not present a clear cleavage plane with the large vessels and had a large caliber intratumoral vasculature. Intraoperative RFA was performed by a very experienced team (interventional radiologist and anesthesiologist to control blood pressure during the procedure). After 2 months, the dose of doxazosin decreased from 16 mg to 8 mg (50% reduction), plasma normetanephrines dropped to 4.6 nmol/L (79%), and the largest tumor diameter at MRI reduced to 6.8 cm (88.8 ml, 57% reduction). After 7 months of the RFA procedure, the tumor continues shrinking (4.8 cm, 45 ml, 78% reduction) and plasma normetanephrine completely normalized. Conclusion: This is the first report of intraoperative RFA of a large primary unresectable paraganglioma. The patient presented a striking clinical success, complete biochemical remission and an objective tumor response. Support: Sao Paulo Research Foundation (FAPESP) grant 2019/15873-6 (to M.Q. Almeida). Presentation: Saturday, June 17, 2023 Oxford University Press 2023-10-05 /pmc/articles/PMC10557017/ http://dx.doi.org/10.1210/jendso/bvad114.311 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Adrenal (Excluding Mineralocorticoids)
de Magalhães, Isabelle P A
Boger, Bibiana S
Gomes, Nathalia L R A
Martins, Guilherme L P
Bomfim, Leomarques A
Fagundes, Gustavo F C
Afonso, Ana Caroline F
Petenuci, Janaina
Coelho, Fernando M A
Srougi, Victor
Tanno, Fabio Y
Chambo, Jose L
Latronico, Ana Claudia
Fragoso, Maria Candida B V
Hoff, Ana O
Mendonca, Berenice B
Menezes, Marcos R
Almeida, Madson Q
SAT307 Intraoperative Radiofrequency Ablation Of An Unresectable Abdominal Paraganglioma Promoted Objective Tumor Response And Complete Biochemical Remission
title SAT307 Intraoperative Radiofrequency Ablation Of An Unresectable Abdominal Paraganglioma Promoted Objective Tumor Response And Complete Biochemical Remission
title_full SAT307 Intraoperative Radiofrequency Ablation Of An Unresectable Abdominal Paraganglioma Promoted Objective Tumor Response And Complete Biochemical Remission
title_fullStr SAT307 Intraoperative Radiofrequency Ablation Of An Unresectable Abdominal Paraganglioma Promoted Objective Tumor Response And Complete Biochemical Remission
title_full_unstemmed SAT307 Intraoperative Radiofrequency Ablation Of An Unresectable Abdominal Paraganglioma Promoted Objective Tumor Response And Complete Biochemical Remission
title_short SAT307 Intraoperative Radiofrequency Ablation Of An Unresectable Abdominal Paraganglioma Promoted Objective Tumor Response And Complete Biochemical Remission
title_sort sat307 intraoperative radiofrequency ablation of an unresectable abdominal paraganglioma promoted objective tumor response and complete biochemical remission
topic Adrenal (Excluding Mineralocorticoids)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557017/
http://dx.doi.org/10.1210/jendso/bvad114.311
work_keys_str_mv AT demagalhaesisabellepa sat307intraoperativeradiofrequencyablationofanunresectableabdominalparagangliomapromotedobjectivetumorresponseandcompletebiochemicalremission
AT bogerbibianas sat307intraoperativeradiofrequencyablationofanunresectableabdominalparagangliomapromotedobjectivetumorresponseandcompletebiochemicalremission
AT gomesnathalialra sat307intraoperativeradiofrequencyablationofanunresectableabdominalparagangliomapromotedobjectivetumorresponseandcompletebiochemicalremission
AT martinsguilhermelp sat307intraoperativeradiofrequencyablationofanunresectableabdominalparagangliomapromotedobjectivetumorresponseandcompletebiochemicalremission
AT bomfimleomarquesa sat307intraoperativeradiofrequencyablationofanunresectableabdominalparagangliomapromotedobjectivetumorresponseandcompletebiochemicalremission
AT fagundesgustavofc sat307intraoperativeradiofrequencyablationofanunresectableabdominalparagangliomapromotedobjectivetumorresponseandcompletebiochemicalremission
AT afonsoanacarolinef sat307intraoperativeradiofrequencyablationofanunresectableabdominalparagangliomapromotedobjectivetumorresponseandcompletebiochemicalremission
AT petenucijanaina sat307intraoperativeradiofrequencyablationofanunresectableabdominalparagangliomapromotedobjectivetumorresponseandcompletebiochemicalremission
AT coelhofernandoma sat307intraoperativeradiofrequencyablationofanunresectableabdominalparagangliomapromotedobjectivetumorresponseandcompletebiochemicalremission
AT srougivictor sat307intraoperativeradiofrequencyablationofanunresectableabdominalparagangliomapromotedobjectivetumorresponseandcompletebiochemicalremission
AT tannofabioy sat307intraoperativeradiofrequencyablationofanunresectableabdominalparagangliomapromotedobjectivetumorresponseandcompletebiochemicalremission
AT chambojosel sat307intraoperativeradiofrequencyablationofanunresectableabdominalparagangliomapromotedobjectivetumorresponseandcompletebiochemicalremission
AT latronicoanaclaudia sat307intraoperativeradiofrequencyablationofanunresectableabdominalparagangliomapromotedobjectivetumorresponseandcompletebiochemicalremission
AT fragosomariacandidabv sat307intraoperativeradiofrequencyablationofanunresectableabdominalparagangliomapromotedobjectivetumorresponseandcompletebiochemicalremission
AT hoffanao sat307intraoperativeradiofrequencyablationofanunresectableabdominalparagangliomapromotedobjectivetumorresponseandcompletebiochemicalremission
AT mendoncabereniceb sat307intraoperativeradiofrequencyablationofanunresectableabdominalparagangliomapromotedobjectivetumorresponseandcompletebiochemicalremission
AT menezesmarcosr sat307intraoperativeradiofrequencyablationofanunresectableabdominalparagangliomapromotedobjectivetumorresponseandcompletebiochemicalremission
AT almeidamadsonq sat307intraoperativeradiofrequencyablationofanunresectableabdominalparagangliomapromotedobjectivetumorresponseandcompletebiochemicalremission